Literature DB >> 32101448

Radiomics: from qualitative to quantitative imaging.

William Rogers1,2, Sithin Thulasi Seetha1,2, Turkey A G Refaee1,3, Relinde I Y Lieverse1, Renée W Y Granzier4,5, Abdalla Ibrahim1,4,6,7, Simon A Keek1, Sebastian Sanduleanu1, Sergey P Primakov1, Manon P L Beuque1, Damiënne Marcus1, Alexander M A van der Wiel1, Fadila Zerka1, Cary J G Oberije1, Janita E van Timmeren1,8,9, Henry C Woodruff1,4, Philippe Lambin1,4.   

Abstract

Historically, medical imaging has been a qualitative or semi-quantitative modality. It is difficult to quantify what can be seen in an image, and to turn it into valuable predictive outcomes. As a result of advances in both computational hardware and machine learning algorithms, computers are making great strides in obtaining quantitative information from imaging and correlating it with outcomes. Radiomics, in its two forms "handcrafted and deep," is an emerging field that translates medical images into quantitative data to yield biological information and enable radiologic phenotypic profiling for diagnosis, theragnosis, decision support, and monitoring. Handcrafted radiomics is a multistage process in which features based on shape, pixel intensities, and texture are extracted from radiographs. Within this review, we describe the steps: starting with quantitative imaging data, how it can be extracted, how to correlate it with clinical and biological outcomes, resulting in models that can be used to make predictions, such as survival, or for detection and classification used in diagnostics. The application of deep learning, the second arm of radiomics, and its place in the radiomics workflow is discussed, along with its advantages and disadvantages. To better illustrate the technologies being used, we provide real-world clinical applications of radiomics in oncology, showcasing research on the applications of radiomics, as well as covering its limitations and its future direction.

Entities:  

Mesh:

Year:  2020        PMID: 32101448      PMCID: PMC7362913          DOI: 10.1259/bjr.20190948

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  110 in total

Review 1.  Computer-aided diagnosis in medical imaging: historical review, current status and future potential.

Authors:  Kunio Doi
Journal:  Comput Med Imaging Graph       Date:  2007-03-08       Impact factor: 4.790

2.  Effect of a computer-aided diagnosis scheme on radiologists' performance in detection of lung nodules on radiographs.

Authors:  T Kobayashi; X W Xu; H MacMahon; C E Metz; K Doi
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

3.  Influence of segmentation margin on machine learning-based high-dimensional quantitative CT texture analysis: a reproducibility study on renal clear cell carcinomas.

Authors:  Burak Kocak; Ece Ates; Emine Sebnem Durmaz; Melis Baykara Ulusan; Ozgur Kilickesmez
Journal:  Eur Radiol       Date:  2019-02-12       Impact factor: 5.315

4.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

5.  Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data.

Authors:  Wentian Guo; Hui Li; Yitan Zhu; Li Lan; Shengjie Yang; Karen Drukker; Elizabeth Morris; Elizabeth Burnside; Gary Whitman; Maryellen L Giger; Yuan Ji
Journal:  J Med Imaging (Bellingham)       Date:  2015-09-23

6.  CT-Based Radiomics Model for Predicting Brain Metastasis in Category T1 Lung Adenocarcinoma.

Authors:  Aiping Chen; Lin Lu; Xuehui Pu; Tongfu Yu; Hao Yang; Lawrence H Schwartz; Binsheng Zhao
Journal:  AJR Am J Roentgenol       Date:  2019-04-01       Impact factor: 3.959

7.  Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer.

Authors:  Shelley Henderson; Colin Purdie; Caroline Michie; Andrew Evans; Richard Lerski; Marilyn Johnston; Sarah Vinnicombe; Alastair M Thompson
Journal:  Eur Radiol       Date:  2017-05-18       Impact factor: 5.315

8.  Deep learning in breast cancer risk assessment: evaluation of convolutional neural networks on a clinical dataset of full-field digital mammograms.

Authors:  Hui Li; Maryellen L Giger; Benjamin Q Huynh; Natalia O Antropova
Journal:  J Med Imaging (Bellingham)       Date:  2017-09-13

9.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach.

Authors:  Hugo J W L Aerts; Emmanuel Rios Velazquez; Ralph T H Leijenaar; Chintan Parmar; Patrick Grossmann; Sara Carvalho; Sara Cavalho; Johan Bussink; René Monshouwer; Benjamin Haibe-Kains; Derek Rietveld; Frank Hoebers; Michelle M Rietbergen; C René Leemans; Andre Dekker; John Quackenbush; Robert J Gillies; Philippe Lambin
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  43 in total

1.  A systematic review of radiomics in osteosarcoma: utilizing radiomics quality score as a tool promoting clinical translation.

Authors:  Jingyu Zhong; Yangfan Hu; Liping Si; Geng Jia; Yue Xing; Huan Zhang; Weiwu Yao
Journal:  Eur Radiol       Date:  2020-09-02       Impact factor: 5.315

2.  Radiomics: Quantitative Radiology transforming Oncology Care.

Authors:  Ian S Boon; Moi H Yap; Tracy P T Au Yong; Cheng S Boon
Journal:  Br J Radiol       Date:  2020-05-06       Impact factor: 3.039

3.  Radiomics in Cardiac MRI: Sisyphean Struggle or Close to the Summit of Olympus?

Authors:  Tim Leiner
Journal:  Radiol Cardiothorac Imaging       Date:  2020-06-25

4.  Artificial intelligence in oral and maxillofacial radiology: what is currently possible?

Authors:  Min-Suk Heo; Jo-Eun Kim; Jae-Joon Hwang; Sang-Sun Han; Jin-Soo Kim; Won-Jin Yi; In-Woo Park
Journal:  Dentomaxillofac Radiol       Date:  2020-11-16       Impact factor: 2.419

5.  125 years of BJR and radiological research: reflecting on the anniversary series in celebration of the world's oldest radiology journal.

Authors:  Simon A Jackson; Kevin M Prise
Journal:  Br J Radiol       Date:  2021-01-01       Impact factor: 3.039

Review 6.  Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice.

Authors:  Michela Roberto; Andrea Botticelli; Martina Panebianco; Anna Maria Aschelter; Alain Gelibter; Chiara Ciccarese; Mauro Minelli; Marianna Nuti; Daniele Santini; Andrea Laghi; Silverio Tomao; Paolo Marchetti
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

7.  An imageomics and multi-network based deep learning model for risk assessment of liver transplantation for hepatocellular cancer.

Authors:  Tiancheng He; Joy Nolte Fong; Linda W Moore; Chika F Ezeana; David Victor; Mukul Divatia; Matthew Vasquez; R Mark Ghobrial; Stephen T C Wong
Journal:  Comput Med Imaging Graph       Date:  2021-03-11       Impact factor: 4.790

8.  The need for standards for COVID-19 quantitative imaging analysis applications.

Authors:  Javier J Zulueta
Journal:  Clin Imaging       Date:  2021-05-19       Impact factor: 1.605

9.  Radiomics and Machine Learning with Multiparametric Breast MRI for Improved Diagnostic Accuracy in Breast Cancer Diagnosis.

Authors:  Isaac Daimiel Naranjo; Peter Gibbs; Jeffrey S Reiner; Roberto Lo Gullo; Caleb Sooknanan; Sunitha B Thakur; Maxine S Jochelson; Varadan Sevilimedu; Elizabeth A Morris; Pascal A T Baltzer; Thomas H Helbich; Katja Pinker
Journal:  Diagnostics (Basel)       Date:  2021-05-21

10.  CT-Based Radiomics Analysis for Preoperative Diagnosis of Pancreatic Mucinous Cystic Neoplasm and Atypical Serous Cystadenomas.

Authors:  Tiansong Xie; Xuanyi Wang; Zehua Zhang; Zhengrong Zhou
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.